Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function. - Wikidata - awgldk - TriplyDB

Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function.

Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function.

http://www.wikidata.org/entity/Q33730962

about

Complexity of pathomechanisms leading to diastolic heart failure in diabetes mellitus - potential field for therapeutic interventions?Novel ASK1 inhibitor AGI-1067 improves AGE-induced cardiac dysfunction by inhibiting MKKs/p38 MAPK and NF-κB apoptotic signaling

P2860

Q41691054-D1BA1BAC-02A4-478E-A740-8A617FEC90B3 Q58768139-931A3FE1-A70F-4009-BC9E-BDE29C6F9FB7

P2860

Advanced glycation end products in children with type 1 diabetes and early reduced diastolic heart function.

http://www.wikidata.org/entity/Q33730962

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Advanced glycation end product ...... uced diastolic heart function.

@ast

Advanced glycation end product ...... uced diastolic heart function.

@en

type

label

Advanced glycation end product ...... uced diastolic heart function.

@ast

Advanced glycation end product ...... uced diastolic heart function.

@en

prefLabel

Advanced glycation end product ...... uced diastolic heart function.

@ast

Advanced glycation end product ...... uced diastolic heart function.

@en

P1433

Q33730962-3833E268-482F-40FF-ABF7-A938F3876EDB

P1476

Q33730962-986D6E59-FBA8-4099-9E6D-439513D58EB9

P2093

Q33730962-089CA355-BE22-46C9-9E37-99EB23262AFD

Q33730962-4EFA0328-E807-45DA-9461-6362BA8142AF

Q33730962-5717BD9C-E112-49A3-9A0A-2030DAB4237C

Q33730962-62F81A37-C6E5-49F8-B939-BDFDC24ED47C

Q33730962-72F79998-C975-4D7C-BBB9-034A93E1A9D1

Q33730962-87CC3098-37C3-4891-A93B-3C91B8392CAC

Q33730962-E8808F30-610A-4654-A25C-8E641491F42E

P2860

Q33730962-049F2F8A-646E-4673-90B1-6B047597996F

Q33730962-110939EB-EED4-44AE-A8C7-B350DF498BEC

Q33730962-114A4922-A573-456D-95AB-9215C954478E

Q33730962-191C9C9D-B31D-4DE0-A2F5-B7B971779108

Q33730962-1D64B899-A715-445D-9A47-A50BDBFC81DD

Q33730962-2B7E0274-7ABE-4193-A58B-CE0E1DBC5057

Q33730962-2F8062B5-7783-4405-B912-44CBCC95E897

Q33730962-452EE0DD-6EB7-4CA6-BF09-0F66CAD1057C

Q33730962-4EC72B7F-2288-4103-B650-215734C4AA9E

Q33730962-547F0529-5516-4C13-848D-EA57FBE98F50

P2888

Q33730962-AF0BC5A9-F906-4A47-A25F-248E6F6F9F2A

P304

Q33730962-7ADC95B1-895A-4515-A141-33EA2401251C

P31

Q33730962-BD753CEC-351A-4D2B-88D5-EC0FEF199081

P356

Q33730962-8735D09A-2429-4D89-8558-3ADCFE40A24F

P433

Q33730962-CCA39F66-E2E4-410F-A899-5277589FE8F3

P478

Q33730962-27F74DA7-7514-4487-B5F5-81C1F526361B

P50

Q33730962-FB2A2C22-6198-4D00-AA45-F0A3050101DA

P577

Q33730962-0FE987E5-09E6-4251-83D2-B07B84BFB511

P6179

Q33730962-0E45004A-77F9-43D6-9ED6-1C54D475542D

P698

Q33730962-198F9AD9-58F0-4ABB-A956-5741096E39C8

P921

Q33730962-8C7FE45B-3230-48AB-AB51-C102048E58BA

Q33730962-F673B561-5DF0-4917-A2D9-B0C823EC8926

P932

Q33730962-1DEEE90B-AAB2-44FE-A4A3-F2D5CF897059

P356

S12872-017-0551-0

P1433

BMC Cardiovascular Disorders

P1476

Advanced glycation end product ...... duced diastolic heart function

@en

P2093

Cathrine Brunborg

http://www.w3.org/2001/XMLSchema#string

Drude Fugelseth

http://www.w3.org/2001/XMLSchema#string

Hanna Dis Margeirsdottir

http://www.w3.org/2001/XMLSchema#string

Knut Dahl-Jørgensen

http://www.w3.org/2001/XMLSchema#string

Knut Haakon Stensaeth

http://www.w3.org/2001/XMLSchema#string

Kristian F Hanssen

http://www.w3.org/2001/XMLSchema#string

Leif Brunvand

http://www.w3.org/2001/XMLSchema#string

P2860

Glycation of LDL by methylglyoxal increases arterial atherogenicity: a possible contributor to increased risk of cardiovascular disease in diabetes

The Receptor for Advanced Glycation End Products (RAGE) Specifically Recognizes Methylglyoxal-Derived AGEs

Advanced glycation end products and diabetic complications

Biochemistry and molecular cell biology of diabetic complications

Glucosepane is a major protein cross-link of the senescent human extracellular matrix. Relationship with diabetes

Subclinical Alterations of Cardiac Mechanics Present Early in the Course of Pediatric Type 1 Diabetes Mellitus: A Prospective Blinded Speckle Tracking Stress Echocardiography Study.

Advanced glycation endproduct (AGE) accumulation and AGE receptor (RAGE) up-regulation contribute to the onset of diabetic cardiomyopathy.

Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress

Diabetic cardiomyopathy, causes and effects.

Early signs of atherosclerosis in diabetic children on intensive insulin treatment: a population-based study.

P2888

s12872-017-0551-0

P304

133

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12872-017-0551-0

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085596701

http://www.w3.org/2001/XMLSchema#string

P698

28545398

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

P932

5445493

http://www.w3.org/2001/XMLSchema#string